Molina Healthcare (MOH) Earns News Sentiment Rating of 0.08
Media headlines about Molina Healthcare (NYSE:MOH) have trended somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Molina Healthcare earned a news sentiment score of 0.08 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.5407999107651 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
These are some of the headlines that may have impacted Accern’s scoring:
- Molina Healthcare Inc (MOH) Downgraded by Zacks Investment Research (americanbankingnews.com)
- Molina Healthcare (MOH) and Its Rivals Financial Survey (americanbankingnews.com)
- Recommendation Hold on Healthcare Stock: Molina Healthcare, Inc. (MOH) – Street Observer (press release) (streetobserver.com)
- Technical Facts to Know: Molina Healthcare, Inc. (MOH) traded -7.14% away from 52-Week High – Voice Of Analysts (analystsbuzz.com)
- John C. Molina Sells 22,400 Shares of Molina Healthcare Inc (MOH) Stock (americanbankingnews.com)
Shares of Molina Healthcare (MOH) opened at 67.40 on Wednesday. Molina Healthcare has a one year low of $42.56 and a one year high of $72.79. The stock has a 50 day moving average of $63.80 and a 200 day moving average of $61.96. The stock’s market cap is $3.85 billion.
Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, August 2nd. The company reported ($0.01) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.86 by ($0.87). Molina Healthcare had a negative net margin of 4.60% and a negative return on equity of 56.81%. The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.88 billion. During the same period last year, the business earned $0.67 EPS. The firm’s quarterly revenue was up 14.7% on a year-over-year basis. On average, analysts forecast that Molina Healthcare will post ($2.70) EPS for the current year.
Several brokerages have issued reports on MOH. Jefferies Group LLC reiterated a “hold” rating and issued a $72.00 price target on shares of Molina Healthcare in a report on Friday, July 14th. Zacks Investment Research cut Molina Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday. BidaskClub downgraded Molina Healthcare from a “buy” rating to a “hold” rating in a report on Friday, August 4th. Morgan Stanley started coverage on Molina Healthcare in a report on Tuesday, June 6th. They set an “underweight” rating and a $65.00 price objective for the company. Finally, Stifel Nicolaus reaffirmed a “sell” rating and set a $60.00 target price on shares of Molina Healthcare in a research report on Friday, July 14th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $62.90.
COPYRIGHT VIOLATION NOTICE: This news story was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US & international trademark and copyright law. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/04/molina-healthcare-moh-earns-news-sentiment-rating-of-0-08.html.
In related news, Director John C. Molina sold 22,737 shares of the company’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $66.01, for a total value of $1,500,869.37. Following the transaction, the director now owns 563,122 shares in the company, valued at approximately $37,171,683.22. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director John C. Molina sold 22,400 shares of the company’s stock in a transaction dated Thursday, September 28th. The stock was sold at an average price of $67.01, for a total transaction of $1,501,024.00. Following the completion of the transaction, the director now owns 540,722 shares in the company, valued at approximately $36,233,781.22. The disclosure for this sale can be found here. Over the last three months, insiders sold 344,045 shares of company stock worth $22,316,558. Insiders own 6.20% of the company’s stock.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Stock Ratings for Molina Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc. and related stocks with our FREE daily email newsletter.